Why the study?
Do point-of-care troponin assays provide comparable diagnostic performance to central laboratory high-sensitivity troponin assays for predicting myocardial infarction in emergency department patients?
Do point-of-care troponin assays provide comparable diagnostic performance to central laboratory high-sensitivity troponin assays for predicting myocardial infarction in emergency department patients?
Point-of-care troponin assays demonstrate equivalent diagnostic performance to central laboratory high-sensitivity assays for suspected MI, but require eGFR-specific cut-offs in patients with impaired renal function to decrease false-positives.
No takes yet. Share an insight, caveat, or question.
POC cTn assays match hs-TnT performance for MI diagnosis in ED patients; supports POC use while leaving optimal eGFR-adjusted cut-offs open.
Wilke et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: